Shows
Audio Journal of Oncology PodcastRebecca Dent MD: First-Line T-DXd Combination Adds More Than a Year of Progression Free Survival for Patients with Advanced HER2 Positive Breast CancerWith:
Sara M Tolaney MD MPH, Chief, Division of Breast Oncology, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School, Boston USA
And interviews with:
Rebecca Dent MD,
Deputy Chief Executive Officer, National Cancer Center, Singapore
And:
Giuseppe Curigliano MD PhD,
Director, Early Drug Development for Innovative Therapies Division, European Institute of Oncology, University of Milan, Milan, Italy
CHICAGO, USA—Patients with HER2 positive advanced or metastatic breast cancer lived significantly longer without having any return of their disease after treatment with a com...2025-07-3016 min
touchPODCASTIncorporating ADCs into the treatment of mBC: Practical considerations for the community oncologisttouchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is...2025-06-2635 min
DAWbench Radio ShowEpisode 37 : TechBytes 10 : 2025 Music Technology Mid Year Review !TechBytes 10 : 2025 Music Technology Mid Year Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio. We catch up again on what Pete and Chris have been up to since last show, get an overview of NAMM and Super Booth, Petes work on MIDI 2.0, WoA Dev, and the inbox Windows ASIO Driver, etc We do a general catch up and summary of the last 12 Months in DAWbench testing and development work. Revisit thread management on respective DAW’s, highlighting the add...2025-06-242h 15
CME in Minutes: Education in Oncology & HematologyAditya Bardia, MD / Giuseppe Curigliano, MD, PhD - Sequencing in the Real World With Complex Patient Types, Including Underrepresented PopulationsPlease visit answersincme.com/860/27391-replay2 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts illustrate how to sequence available therapies for HR+, HER2- metastatic breast cancer. Upon completion of this activity, participants should be better able to: Review the expert recommendations regarding a sequential approach to the use of ADCs for HR+, HER2- metastatic breast cancer (mBC) management; and Outline evidence-based clinical strategies to enhance a sequential therapeutic approach in real-world patient populations.2025-06-0320 minDAWbench Radio ShowEpisode 36 : Honouring the Legendary : Bob Moog Foundation : Innovation, Inspiration, and Igniting Creativity !Honouring the Legendary : Bob Moog Foundation : Innovation, Inspiration, and Igniting Creativity ! " It's Moog, Rhymes with Vogue ! " Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft, and special guest Michelle Moog-Koussa who is the founder and Executive Director of the Bob Moog Foundation , which she established in 2006 to honour the legacy of her father, Bob Moog , who is the legendary and revolutionary music tech pioneer that invented the first commercial analog synthesizer. We discuss Bob Moog's early history first building and selling Theremins in his teens...2025-05-311h 53
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastProf. Giuseppe Curigliano, MD, PhD - Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-MakingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient...2025-05-1344 min
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastProf. Giuseppe Curigliano, MD, PhD - Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-MakingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient...2025-05-1344 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastProf. Giuseppe Curigliano, MD, PhD - Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-MakingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient...2025-05-1344 min
PeerView Clinical Pharmacology CME/CNE/CPE VideoProf. Giuseppe Curigliano, MD, PhD - Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-MakingThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/VPA865. CME/EBAC/NCPD/AAPA/IPCE credit will be available until April 26, 2026.Illuminating a Better Path Forward for HR+, HER2- MBC: Bridging the Science and Art of Medicine in Clinical Decision-Making In support of improving patient...2025-05-1344 minDAWbench Radio ShowEpisode 35 : The Master of Synthesizer Design : Axel Hartmann : From Inspiration to Iconic !The Master of Synthesizer Design : Axel Hartmann : From Inspiration to Iconic ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft, and special guest Axel Hartmann who has been the go to designer for some of the most iconic synthesizers of the last 35 years, and continues to be one of the leading designers in the field. Chances are, you have seen or played one of his designs. We discuss Axel's history in music and technology, what lead him to follow the path to Industrial Design, and what motivated a...2025-04-112h 39PeerView Clinical Pharmacology CME/CNE/CPE VideoProf. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical ImpactThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAPA credit will be available until January 27, 2026.A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact In support of improving patient care...2025-02-061h 01PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastProf. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical ImpactThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAPA credit will be available until January 27, 2026.A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact In support of improving patient care...2025-02-061h 01
PeerView Internal Medicine CME/CNE/CPE Video PodcastProf. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical ImpactThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAPA credit will be available until January 27, 2026.A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact In support of improving patient care...2025-02-061h 01
PeerView Internal Medicine CME/CNE/CPE Audio PodcastProf. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical ImpactThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAPA credit will be available until January 27, 2026.A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact In support of improving patient care...2025-02-061h 01PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastProf. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical ImpactThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAPA credit will be available until January 27, 2026.A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact In support of improving patient care...2025-02-061h 01PeerView Oncology & Hematology CME/CNE/CPE Video PodcastProf. Giuseppe Curigliano, MD, PhD - A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical ImpactThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/TQX865. CME/MOC/NCPD/AAPA credit will be available until January 27, 2026.A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact In support of improving patient care...2025-02-061h 01
OncLive® On AirDESTINY-Breast06 Data Demonstrate the Role of T-DXd in HER2-Low and -Ultralow Breast Cancer: With Chandler Park, MD; and Guiseppe Curigliano, MD, PhDIn this episode of Oncology Unplugged, a podcast series from MedNews Week, host Chandler Park, MD, a medical oncologist at the Norton Cancer Institute in Louisville, Kentucky, was joined by Guiseppe Curigliano, MD, PhD, a full professor of medical oncology at the University of Milan, as well as the director of the Early Drug Development Division and co-chair for the Experimental Therapeutics Program at the European Institute of Oncology in Italy.
In this exclusive interview, Drs Park and Curigliano discussed the potential future role of artificial intelligence across oncology disciplines; how advances in precision medicine will help improve p...2025-01-0118 min
Research To Practice | Oncology VideosHER2-Low and HER2-Ultralow Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast CancerFeaturing perspectives from Dr Aditya Bardia, Prof Giuseppe Curigliano, Dr Hope S Rugo and Dr Antonio C Wolff, including the following topics: Introduction (0:00) Optimizing the Identification of HER2-Low and HER2-Ultralow Breast Cancer — Dr Wolff (2:28) Available Data with HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Disease — Dr Bardia (23:16) Practical Applications of HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Metastatic Breast Cancer — Prof Curigliano (51:31) Future Directions for HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Breast Cancer — Dr Rugo (1:11:57) CME information and select publications2024-12-231h 31
Breast Cancer UpdateHER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1Dr Aditya Bardia, Professor Giuseppe Curigliano, Dr Hope Rugo and Dr Antonio C Wolff share their perspectives on the management of HER2-low breast cancer and the potential role of emerging data from SABCS 2024.2024-12-231h 31
Oncology Today with Dr Neil LoveHER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1Featuring a discussion on data from SABCS 2024 and the management of HER2-low breast cancer with Drs Bardia, Curigliano, Rugo and Wolff, moderated by Dr Neil Love. Produced by Research To Practice.CME information and select publications here2024-12-231h 31
Medical Digest & Congress ReportEfficacy and Safety of Trastuzumab Deruxtecan vs Physician’s Choice of Chemotherapy by Pace of Disease Progression on Prior Endocrine-based Therapy - report from SABCS2024Prof. Giuseppe Curigliano presents the data of the DESTINY-Breast06 at San Antonio Breast Cancer Symposium 2024.
Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-trastuzumab-deruxtecan-vs-physicians-choice-chemotherapy-pace-disease-progression-prior-endocrine-based-therapy2024-12-2002 minDAWbench Radio ShowEpisode 34 : The Art Of Analog Modeling II : Cherry Audio : Reviving Analog Legends !The Art Of Analog Modeling II : Cherry Audio : Reviving Analog Legends ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft, and special guests Dan Goldstein (CTO) and Mitchell Sigman (Lead Designer) @ Cherry Audio. We discuss Dan and Mitchell's history with music and technology, their shared passion for early synths and computers, and how their paths merged at Cherry Audio. We discuss Dan's early coding career at Sonic Foundry, his initial explorations with analog physical modeling, and how that set the foundations for later developments explored at Cherry...2024-12-183h 12
TJ TalksHow to craft the new avenues for precision oncologyA scientific society for integrating all aspects of cancer care - diagnostics, pathology, surgery, radiation, and medical oncology -through a multidisciplinary approach, because the future of medical oncology will focus on understanding cancer biology and intercepting the disease before it appears or recurs.In this TJ Talks, prof. Giuseppe Curigliano, chair of the Division of Early Drug Development at the European Institute of Oncology in Milan, and professor at the University of Milan School of Medicine, talks with prof. Giancarlo Pruneri on the future of precision oncology and his commitment as President-elect of ESMO.See omnystudio.c...2024-11-1310 minDAWbench Radio ShowEpisode 33 : Music Tech Pioneers V : Peter Gorges: Wizoo to UJAM and Beyond !Music Tech Pioneers V : Peter Gorges: Wizoo to UJAM and Beyond ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Peter Gorges who has been involved with the ever evolving area of Music Technology in varying capacities for over 4 decades, from sound design, authoring and publishing, journalism, to co-founding numerous innovative Music Software companies. We discuss Peters' early history with music and technology , and how that lead a path to his initial explorations in synth programming and sound design , his continuing journey to working...2024-11-032h 45
Oncology Times - OncTimes TalkGlobal Cooperation on Antibody-Drug Conjugates: Key Driver of Progress in HER2-Dependent Metastatic Breast Cancer TreatmentAn assessment of progress with antibody-drug conjugates (ADCs) for the treatment of HER2-dependent metastatic breast cancer was given at the 2024 Chinese Society of Clinical Oncology (CSCO) Annual Meeting. The President-Elect of the European Society for Medical Oncology (ESMO), Giuseppe Curigliano, MD, PhD, Director of the Early Drug Development for Innovative Therapies Division at the European Institute of Oncology and the University of Milano in Italy, told Oncology Times reporter Peter Goodwin about the broadening scope of ADCs in breast cancer and his reasons for encouraging ESMO and CSCO to continue to expand their co-operation.2024-10-0708 min
OncTimes TalkGlobal Cooperation on Antibody-Drug Conjugates: Key Driver of Progress in HER2-Dependent Metastatic Breast Cancer TreatmentAn assessment of progress with antibody-drug conjugates (ADCs) for the treatment of HER2-dependent metastatic breast cancer was given at the 2024 Chinese Society of Clinical Oncology (CSCO) Annual Meeting. The President-Elect of the European Society for Medical Oncology (ESMO), Giuseppe Curigliano, MD, PhD, Director of the Early Drug Development for Innovative Therapies Division at the European Institute of Oncology and the University of Milano in Italy, told Oncology Times reporter Peter Goodwin about the broadening scope of ADCs in breast cancer and his reasons for encouraging ESMO and CSCO to continue to expand their co-operation.2024-10-0708 minDAWbench Radio ShowEpisode 32 : DAW Evolution IX : Reaper - Revisited !DAW Evolution IX : Reaper - Revisited ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-hosts Pete Brown of Microsoft and Erin McKimm, and returning special guest Justin Frankel, who is the Founder and Lead Developer of Reaper. We catch up after 5 years since the last show , with a general overview of whats been happening since we last spoke in Music Tech/Reaperland. We discuss the milestone releases since the last show, covering V5-V7 which saw over 100 updates during that time , and the ongoing company culture and philosophy towards...2024-08-251h 43
Research To Practice | Oncology VideosMetastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast CancerFeaturing an interview with Prof Giuseppe Curigliano, including the following topics: Counseling patients with newly diagnosed metastatic breast cancer (mBC); role of patient-reported outcomes and advocacy (0:00) Individualized selection of up-front therapy for patients with HR-positive, HER2-negative mBC (6:02) Selection and sequencing of treatment for patients with HR-positive, HER2-negative disease who experience progression on CDK4/6 inhibition (9:40) Current and future role of HER2-targeted therapy for HER2-low and HER2-ultralow mBC (19:46) Selection and sequencing of therapy for patients with metastatic triple-negative breast cancer (29:53) Emerging innovative interventions for the treatment of mBC (37:17) CME information and select publications2024-08-2345 minBreast Cancer UpdateOncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast CancerProf Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer.2024-08-2346 min
Oncology Today with Dr Neil LoveAn interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the management of metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
2024-08-2346 minDAWbench Radio ShowEpisode 31 : TechBytes 09 : 2024 Music Technology Mid Year Review !TechBytes 09 : 2024 Music Technology Mid Year Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio. We catch up on what Pete and Chris have been up to since last show, Petes overview of MS Build Event - CoPilot+, AI avalanche incoming, Recall, required TOPs - (Tera Operations Per Second), etc. We cover Computex and detail Intel, AMD and Apples response to the hype/hysteria of AI, AI, AI, AI....., Sigh ! We do a general catch up and s...2024-08-012h 52
OncLive® On AirCurigliano on the DESTINY-Breast06 Trial in HER2-Low and -Ultralow Metastatic Breast CancerDr Curigliano discusses the DESTINY-Breast06 trial of trastuzumab deruxtecan in patients with HER2-low or HER2-ultralow metastatic breast cancer.2024-07-1510 min
Research To Practice | Oncology VideosMetastatic Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast CancerFeaturing perspectives from Dr Aditya Bardia, Dr Harold J Burstein, Prof Giuseppe Curigliano, Dr Sara A Hurvitz, Dr Hope S Rugo and Dr Joyce O’Shaughnessy, moderated by Dr Rugo, including the following topics: Introduction (0:00) Optimizing the Management of HER2-Positive Metastatic Breast Cancer (mBC) — Dr Hurvitz (4:38) Individualized Selection of Up-Front Therapy for Patients with HR-Positive, HER2-Negative mBC — Dr Burstein (30:11) Selection and Sequencing of Treatment for Patients with HR-Positive, HER2-Negative mBC Who Experience Disease Progression on CDK4/6 Inhibition — Dr Rugo (48:15) Current and Future Role of HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Disease — Prof Curigliano (1:07:2...2024-06-281h 59
Novità per il mondo dell'Oncologia06 - DESTINYCon i nuovi risultati degli studi DESTINY sembra proprio che le prospettive per gli anticorpi coniugati debbano cambiare: dallo sfruttamento di target sovraespressi (HER2 nel caso specifico), alla comprensione del ruolo di minime espressioni e allo sviluppo - proprio del tipo “tumor agnostic” - in caso di mutazioni attivanti presenti in neoplasie diverse.BibliografiaCurigliano G, et al. Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therap...2024-06-2805 minOncology Times - OncTimes TalkTrastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine TherapyData from the DESTINY Breast06 trial using the antibody-drug conjugate trastuzumab deruxtecan to treat patients with estrogen receptor positive (HR+), human epidermal growth factor receptor-low (HER2-low), and HER2-ultralow breast cancer after endocrine therapy, show longer progression-free survival in comparison with standard chemotherapy.
After announcing the results at the 2024 ASCO Annual Meeting, first author Giuseppe Curigliano, MD, PhD, Director of Early Drug Development for the Innovative Therapies Division of the European Institute of Oncology, discussed the findings with Oncology Times correspondent Peter Goodwin2024-06-1808 minOncTimes TalkTrastuzumab Deruxtecan Delays Progression in HR+, HER2-low, and HER2 Ultralow Breast Cancer After Endocrine TherapyData from the DESTINY Breast06 trial using the antibody-drug conjugate trastuzumab deruxtecan to treat patients with estrogen receptor positive (HR+), human epidermal growth factor receptor-low (HER2-low), and HER2-ultralow breast cancer after endocrine therapy, show longer progression-free survival in comparison with standard chemotherapy. After announcing the results at the 2024 ASCO Annual Meeting, first author Giuseppe Curigliano, MD, PhD, Director of Early Drug Development for the Innovative Therapies Division of the European Institute of Oncology, discussed the findings with Oncology Times correspondent Peter Goodwin2024-06-1808 min
Oncology On The GoApplying Updated Breast Cancer Findings From ASCO to Clinical PracticeFollowing the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Neil M. Iyengar, MD, and Paolo Tarantino, MD, co-hosted a live X Space with CancerNetwork® and discussed the latest trial updates that may impact clinical practice in the breast cancer field.
Iyengar is an associate attending physician at Memorial Sloan Kettering Cancer Center and a co-editor-in-chief of ONCOLOGY®. Tarantino is a clinical research fellow at Dana-Farber Cancer Institute and Harvard Medical School.
Iyengar and Tarantino discussed data regarding several trials and studies presented at the meeting. These presentations included:
· Phase 3 DESTINY-Breast06 Trial (N...2024-06-1731 minDAWbench Radio ShowEpisode 30 : The Art of Virtual Synth Design : Dawesome - From Oscillators, Chaos Theory, Granular and Beyond !The Art of Virtual Synth Design : Dawesome - From Oscillators, Chaos Theory, Granular and Beyond ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Erin McKimm, and also special guest Peter Volaender : aka Dawesome : who is the founder and lead developer at Dawesome Music. We discuss Peters personal history with audio, music and technology, coding and his eventual journey to founding Dawesome Music, and how he commenced developing his synthesizer designs. We cover Peters early explorations with AI, starting in the late 90's , his philosophical, innovative and unique approach...2024-06-172h 33DAWbench Radio ShowEpisode 29 : DAW Evolution VIII : Tracktion - Past, Present, Future ! DAW Evolution VIII : Tracktion - Past, Present, Future ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Jules Storer who is the Founder and Lead Developer of Tracktion, now known as Tracktion Waveform, and also the developer of the JUCE programming framework. We discuss Jules' early history with music, computers and coding, and how that lead a path to his development of Tracktion. We cover the history from Tracktions early days under the Mackie banner, the splitting and development of JUCE as a...2024-05-071h 57DAWbench Radio ShowEpisode 28 : MIDI 2.0 : 40 Years in the Making !MIDI 2.0 : 40 Years in the Making ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Pete Brown of Microsoft and also special guests, Andrew Mee , who is a MIDI 2.0 consultant to Yamaha, and Gary Daniels of Microsoft. Andrew is the author of open source libraries, and also tools for certification for MIDI 2.0, as well as being Chair for the Developer Support Working Group for the MIDI Association. Gary is an Engineer on the Microsoft Audio Team, and is the architect of Windows MIDI Services, and primary developer for the Service, D...2024-04-081h 49
IgeaEp. 24 - Il posticipo dei nuovi LEA e gli infermieri stranieri che lasciano l'UKQuesta settimana sono stati posticipati i nuovi LEA, è partito il Registro nazionale sulle protesi mammarie, è stato licenziato dal Consiglio dei ministri il DDL Semplificazioni, Schillaci ha proposto un nuovo Presidente per l’Aifa e l’oncologo Giuseppe Curigliano è stato intervistato sul tumore al seno in Italia.A livello internazionale, parleremo della terapia Car-T indiana che costa un decimo rispetto all’Occidente, dello psicologo statunitense che ha fatto molto parlare di sé per il suo ultimo libro, di diritto all’aborto negli Stati Uniti e in Croazia e degli infermieri stranieri che stanno lasciando il Regno Unito. Per iscrivers...2024-03-2914 minDAWbench Radio ShowEpisode 27 : TechBytes 08 : 2023 Music Technology in Review !TechBytes 08 : 2023 Music Technology In Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio. We cover whats been happening in the land of DAWbench, and whats in store for 2024. We discuss how far the session templates have grown over a 10 year period to cover the scaling in CPU performance , and revisit some alternate DAW benchmarking work being done by others. Pete gives a first hand round up of NAMM 2024 , we discuss the participation with the return of the show back t...2024-03-152h 20
Giorno per giornoUltime notizie (quasi tutte buone) dal fronte della guerra al cancroIn questi giorni si è parlato di importanti progressi della ricerca, come il farmaco che fa «sparire» le metastasi generate da un tipo di tumore ai polmoni o il proseguimento della sperimentazione dei vaccini a mRna contro il melanoma. Nel frattempo, però, nel nostro Paese aumentano i casi di malattia sotto i 50 anni. Vera Martinella e l’oncologo Giuseppe Curigliano fanno il punto sulla situazione.Per altri approfondimenti:Tumore ai polmoni, un nuovo farmaco fa “sparire” le metastasi e ferma la progressione della malattiaA Napoli somministrata la prima dose italiana di vaccino per il melanomaSportello Cancro, il portale web del Co...2024-02-0212 minDAWbench Radio ShowEpisode 26 : The Art of Sound Design : Soundly : Sound Creation, Cataloguing & Archival !The Art of Sound Design : Soundly : Sound Creation, Cataloguing & Archival ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Erin McKimm, and also special guest Peder Jogensen , who is the Co-Founder , CEO and CTO of Soundly We discuss Peders personal history with audio, music and technology, sound effects and design, coding and his eventual journey to founding Soundly. We cover the history of Soundly and its milestone releases and feature additions , the creation, expansion and cataloging of the cloud SFX library, the introduction o...2023-09-031h 53touchPODCASTNew and emerging agents in HER2-negative metastatic breast cancer Implications for current and future practicetouchPANEL DISCUSSION for touchONCOLOGY
Listen to three breast cancer experts discuss the expanding targeted treatment options for HER2-negative metastatic breast cancer, with a focus on approved and emerging antibody drug conjugates and considerations for their use in clinical practice.
The experts
Prof. Giuseppe Curigliano, University of Milan, Milan, Italy
Prof. Hope Rugo, University of California, San Francisco, CA, USA
Prof. Peter Schmid, Barts Cancer Institute, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is j...2023-08-1435 minDAWbench Radio ShowEpisode 25 : TechBytes 07 : 2023 Music Technology Mid Year Review !TechBytes 07 : 2023 Music Technology Mid Year Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio. We cover the release of DAWbench Suite 2023, detail the changes and additions and also discuss some alternate DAW benchmarking work being done by others. Pete and Chris give a first hand round up of their personal views and experiences at NAMM 2023 , while covering some cool new products and developing trends. We again cover the increasing trend of acquisitions and mergers, navigate and resolve co...2023-08-022h 58
Research To Practice | Oncology VideosOncology Today with Dr Neil Love — HER2-Positive Metastatic Breast CancerFeaturing perspectives from Dr Joyce O’Shaughnessy, including the following topics: Introduction (0:00) HER2-Positive Metastatic Breast Cancer –– Professor Giuseppe Curigliano, MD, PhD (8:04) ASCO 2023 Preview (38:37) NCPD information and select publications2023-06-011h 02DAWbench Radio ShowEpisode 24 : Digital Audio Editing and Restoration : Acon Digital : Mastering the Art !Digital Audio Editing and Restoration : Acon Digital : Mastering the Art ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Pete Brown of Microsoft and special guest Stian Aagedal , who is the Founder and Lead Developer of Acon Digital. We discuss Stians early musical and technical explorations that lead him to found Acon Digital, navigate the history and ongoing development and milestone releases of Acoustica, and the Restoration and Mastering Plugin Suites. We dive in to the area's of Machine Learning, Neural Networks and AI advances not only in a...2023-03-271h 33DAWbench Radio ShowEpisode 23 : DAW Evolution VII : n-Track Studio - Past, Present, Future !DAW Evolution VII : n-Track Studio - Past, Present, Future ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Flavio Antonioli who is the Founder of n-Track Studio. We discuss Flavio's early history with computers, technology and coding , and how that lead a path to his founding and development of n-Track. We cover the history and the ongoing challenges of maintaining the development of the application across multiple platforms, both desktop and mobile. We take a deep dive into the various milestone versions...2023-03-101h 37DAWbench Radio ShowEpisode 22 : Music Tech Pioneers IV : Marcus Ryle : 4 Decades of Music Tech Innovation !Music Tech Pioneers IV : Marcus Ryle : 4 Decades of Music Tech Innovation ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Marcus Ryle , whose career spans over 4 decades on the front line of Music Tech Innovation. We discuss Marcus' early history with music and technology , and how that lead a path to starting his career at Oberheim. We cover his involvement in the development of some of the final iconic products at Oberheim, including the OB-Xa, Expander and Matrix 12. We discuss the fall o...2023-02-092h 27DAWbench Radio ShowEpisode 21 : TechBytes 06 : 2022 Music Technology in Review !TechBytes 06 : 2022 Music Technology in Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio. Comeback show after an extended break. We cover the last batch of DAWbench and alternate testing results, and weigh up the +/- feedback from the assembled gallery. We discuss some recent acquisitions and mergers, and look back at some from the past that have prospered, and others that have gone south. We cover some of the major new DAW releases, and investigate...2023-01-282h 57
Research To Practice | Oncology VideosOncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer (Companion Video Lecture)Featuring a slide presentation and related discussion from Professor Giuseppe Curigliano, including the following topics: Recent data with targeted therapies for patients with HER2-positive metastatic breast cancer (0:00) Case: A woman in her early 40s with a new right breast tumor 10 years after adjuvant radiation and endocrine therapy (17:17) Case: A woman in her mid 20s with a family history of breast cancer presenting with a lump in her left breast (26:34) CME information and select publications2023-01-2634 min
Research To Practice | Oncology VideosBreast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast CancerFeaturing an interview with Professor Giuseppe Curigliano, including the following topics: Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future (0:00) Optimal treatment of HER2-positive mBC with brain metastases (7:42) Screening for and management of T-DXd-related interstitial lung disease (17:32) Gastric toxicities associated with the tucatinib/trastuzumab/capecitabine regimen and with T-DXd; differences in the toxicity profiles of these therapies between patients with HER2-positive and HER2-low breast cancer (23:50) Approach to endocrine therapy for triple-positive disease; emerging data with the AKT inhibitor capivasertib (28:43) Case: A woman in her mid 40s with a family history...2023-01-2646 minBreast Cancer UpdateOncology Today with Dr Neil Love: HER2-Positive Metastatic Breast CancerFeaturing a discussion of recent advances in the treatment of HER2-positive metastatic breast cancer with Professor Giuseppe Curigliano, moderated by Dr Neil Love.2023-01-2647 min
Oncology Today with Dr Neil LoveHER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano
Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer.
CME information and select publications here.
2023-01-2647 min
Senior Italia FederAnzianiSenior TG - 16 dicembre 2022- L'età media è aumentata di tre anni
- Test Genomici, come evitare la chemioterapia, intervista a Francesco Cognetti, Presidente FOCE
- Da San Antonio i risultati di uno studio di 12 anni, intervista a Giuseppe Curigliano, Direttore Divisione Sviluppo di nuovi farmaci per terapie all'Istituto Europeo di Oncologia di Milano
- 76enne recupera la vista da un occhio con cornea artificiale2023-01-1604 min
OnconewsSABCS 2022 e o impacto na prática clínicaOs destaques do programa científico do San Antonio Breast Cancer Symposium (SABCS 2022) e seu impacto na prática clínica estão em foco no PODCAST ONCONEWS, com apresentação de Silvio Bromberg e Daniel Gimenes. Nesta edição os especialistas recebem Karla Kabbach, patologista do Hospital Israelita Albert Einstein e docente na Universidade Federal de São Paulo (Unifesp), que discute trabalhos que avaliam o status HER2-low e a expressão Ki67 no câncer de mama. Confira.
Referências:
1. Abstract GS1-10 - Primary results from the randomized Phase II RIGHT Choice trial...2022-12-1534 minOnconewsHER2-Low como fator preditivo de resposta à quimioterapia neoadjuvante no câncer de mama inicial e margetuximabe na doença avançado HER2-positivoNo PODCAST ONCONEWS, Silvio Bromberg e Daniel Gimenes comentam artigo publicado no Journal of Clinical Oncology (JCO) com os resultados finais de sobrevida global do estudo randomizado de Fase 3 SOPHIA, que avaliou margetuximabe em comparação com trastuzumabe em pacientes com câncer de mama avançado HER2-positivo previamente tratado. Nesta edição, os especialistas discutem ainda os dados do estudo HELENA, publicado no periódico BMC Cancer, que investiga a resposta à quimioterapia neoadjuvante (NAC) em pacientes com câncer de mama inicial HER2-low de acordo com o escore HER2 (1+ ou 2+ sem amplificação). Confira.
Referências...2022-11-1719 min
La Grande CRivoluzione Biotecnologica in OncologiaCon Giuseppe Curigliano (Istituto Europeo di Oncologia)Come è stato trattato il Cancro nel corso della storia? Come funziona un chemioterapico? Come funziona la radioterapia? Cosa sono i farmaci biologici e perché danno meno effetti collaterali?2022-11-0217 min
All Things Cardio-OncologyRadiation Therapy and Cardio-OncologyOur guest today is Dr. Daniel Cehic, he is an electrophysiologist by training and is currently the chief medical officer at GenesisCare. He trained at the University of Adelaide, Royal Adelaide Hospital, and John Radcliffe Hospital in Oxford, England. He has established CardioOncology clinics in Adelaide and Sydney managing a variety of cardiac complications of cancer therapies and supervising the commencement of similar clinics in other states where GenesisCare has a cardiology presence. He is also the president of ICOS local chapter in Australia. He is interviewed by Felicity Nelson who is a freelance science and health editor based...2022-08-1620 min
PeerPOV: The Pulse on MedicinePhase 3 DESTINY-Breast03 Impresses at ASCO 2022Welcome to this episode of Physician’s Weekly podcast. I am your host Dr Rachel Giles, from Medicom Medical Publishers in collaboration with Physician’s Weekly. This week, we have 2 really interesting interviews about very different topics. I will start with the second interview. The 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, was held 3 -7 June 2022 in Chicago, IL. One of the most covered topics talked in the hallways and you may have read in newspapers, was about precision treatment in aggressive breast cancer. It all started 24 years ago, when a drug called Herceptin changed how doctors...2022-06-0718 minDAWbench Radio ShowEpisode 20 : Music Tech Pioneers III : Sequential Circuits : Rise, Fall, Return !Music Tech Pioneers III : Sequential Circuits : Rise, Fall, Return ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Dave Smith, who is the founder of Sequential Circuits. We discuss Daves early history with music and technology , and how that lead a path to founding Sequential Circuits, the early days exploring analog synths and creating tools to expand their usability, to his work with microprocessors and the eventual development of the revolutionary Prophet 5 Polyphonic synth. We cover his involvement in the development of...2022-05-311h 25DAWbench Radio ShowEpisode 19 : DAW Evolution VI : Pro Tools – Past, Present, Future !DAW Evolution VI : Pro Tools – Past, Present, Future ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Mark Jeffery, who is the the original co-designer and software developer of Pro Edit and Pro Tools, and is currently a Senior Engineer at AVID. We discuss Marks personal history with music , computers and technology, how that lead a path to joining Digidesign in the very early stages of the company, and the eventual journey to fathering Pro Tools. We cover Marks earliest work at Di...2022-05-201h 59DAWbench Radio ShowEpisode 18 : Music Tech Pioneers II : Digidesign : The Early Years !Music Tech Pioneers II : Digidesign : The Early Years ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Evan Brooks, who is the Co-Founder of Digidesign. We discuss Evans early history with computers, technology and coding , and how that lead to co-founding Digidesign , the early adventures which started with developing Drum Sound EPROMs to the development of Sound Designer, Sound Tools and Pro Tools. We take a deep dive into the various challenges and milestones achieved navigating the limited technical capabilities of the...2022-05-122h 03DAWbench Radio ShowEpisode 17 : TechBytes 05 : 2022 Music Technology Quarter Time Review !TechBytes 05 : 2022 Music Technology Quarter Time Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio. We cover the results of the recent BETA testing results of the BUS extension test, and detail the performance variables experienced while we navigated the thread scheduling dips and curves across multiple DAW's. We follow up on the Cubase 12 release and the rollout of the transition from eLicenser, discuss some exciting new Music Tech releases , as well as revisit the continuing fallout of the chip...2022-04-141h 54DAWbench Radio ShowEpisode 16 : Music Tech Pioneers: Propellerhead : ReCycle to Reason !Music Tech Pioneers: Propellerhead : ReCycle to Reason ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Ernst Nathorst-Böös, founder of Reason Studios, formerly known as Propellerhead Software. We discuss Ernst history with music and computer technology , his previous involvement in MI and early experiences within the emerging Music Tech arena, which lead to the founding of the company that brought you Reason. We cover the early years with the successive releases of Recycle, ReBirth and Reason , each individually changing the game at...2022-02-261h 24
Keeping CurrentThe Evolution in Systemic Breast Cancer Therapies: A Deeper Dive Into Recent DataJoin Drs Curigliano and Hamilton as they discuss recent breast cancer clinical trial data and the implications on future clinical practice. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/968174?src=mkm_podcast_addon_9681742022-02-1533 minDAWbench Radio ShowEpisode 15 : TechBytes 04 : 2021 Music Technology in Review !TechBytes 04 : 2021 Music Technology in Review ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Pete Brown of Microsoft and Chris Mann of Link Audio We discuss the final release of DAWbench 2021 Suite, the response, feedback and some of the usual dips and curves navigated after each release We summarise some hits and misses on predictions with the continuing CPU and Platform wars, cover the ongoing fallout of the AKM converter fire and its impact on the industry , and navigate some shifting dots with eLicenser, iLok, and copy protection in g...2022-02-082h 04DAWbench Radio ShowEpisode 14 : DAW Evolution V : Ardour - Past , Present , Future !DAW Evolution V : Ardour - Past , Present , Future ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Paul Davis, who is the Founder and Lead Developer of Ardour. We discuss Paul's early history with computers, technology and coding , and how that lead a path to his involvement and focus in open source, and the eventual development of Ardour. We cover the history and the ongoing challenges of maintaining the unique position of allowing access to the complete source code , and the challenges of managing...2021-12-162h 37DAWbench Radio ShowEpisode 13 : The Art of Analog Modeling : Softube : Tubes & Transistors to Digital Artistry !The Art of Analog Modeling : Softube : Tubes & Transistors to Digital Artistry ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Niklas Odelholm, who is the Co-Founder and VP of Products at Softube. We discuss Niklas' history with music and computer technology and how that lead his journey to meet and sync with the other Softube Co-Founders. We cover the early years from a small start up company navigating the evolving technologies and getting their modeling technology into the hands of 3rd party...2021-11-031h 45Keeping CurrentEmerging Systemic Treatment Options Across the Spectrum of Breast Cancer TherapyJoin Drs Curigliano and Hurvitz as they discuss advances in systemic treatments for HER2-positive, triple-negative, and HR-positive breast cancer. Credit available for this activity expires: [10/26/22] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/961439?src=mkm_podcast_addon_9614392021-10-2736 min
VJOncology PodcastThe Breast Cancer Sessions: Highlights from ASCO 2021VJOncology has assembled an international panel of leading breast cancer experts to discuss the latest advances and data from the virtual American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.
In this podcast, Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, is joined by Giuseppe Curigliano, MD, University of Milan, Milan, Italy, Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, and Andrew Tutt, MBChB, PhD, The Institute of Cancer Research, London, UK, to examine the recent major breakthroughs in breast cancer and what they mean for clinical practice.
Tune in to hear the expert...2021-08-1839 min
VJOncology PodcastThe Breast Cancer Sessions: Highlights from ASCO 2021VJOncology has assembled an international panel of leading breast cancer experts to discuss the latest advances and data from the virtual American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.
In this podcast, Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, is joined by Giuseppe Curigliano, MD, University of Milan, Milan, Italy, Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, and Andrew Tutt, MBChB, PhD, The Institute of Cancer Research, London, UK, to examine the recent major breakthroughs in breast cancer and what they mean for clinical practice.
Tune in to hear the expert...2021-08-1639 minDAWbench Radio ShowEpisode 12: TechBytes 03 : 2021 Music Technology Mid Year !TechBytes 03 : 2021 Music Technology Mid Year ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Pete Brown of Microsoft and special guest Chris Mann, who is the Co Owner and Director of Operations of Link Audio We cover our mutual history in the industry, Chris's early explorations of Computer and Music Technologies, his eventual journey through various chapters of being in the front line of the the music technology wave, to his current ongoing adventures. We bring everyone up to date on what has been happening behind the scenes and...2021-08-012h 17Keeping CurrentOpportunities and Challenges in Early Breast Cancer: Do PARP Inhibitors Have a Role?Dr Curigliano and Dr Loi discuss the latest clinical data regarding the use of PARP inhibitors in early high-risk breast cancer. Credit available for this activity expires: 7/29/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955496?src=mkm_podcast_addon_9554962021-07-3027 min
e-ESO PodcastsCancer patient management during COVID19 pandemicExpert: Giuseppe Curigliano, European Institute of Oncology, Milan, Italy2021-05-1906 minVJOncology PodcastThe Breast Cancer Sessions: a focus on the St. Gallen ConsensusAt the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned St. Gallen International Consensus Session on the optimal treatment of early breast cancer.
In this podcast, St. Gallen Consensus Session Co-Chair Giuseppe Curigliano, MD, PhD, European Institute of Oncology & University of Milan, Milan, Italy, is joined by consensus panelists Lisa Carey, MD, FASCO, The University of North Carolina at Chapel Hill, NC, Hope Rugo, MD, FASCO, University of California, San Francisco, CA, and Fatima Cardoso, MD, Champalimaud Clinical Center, Lisbon, Portugal.
Tune in to hear the...2021-04-2649 minVJOncology PodcastThe Breast Cancer Sessions: a focus on the St. Gallen ConsensusAt the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned St. Gallen International Consensus Session on the optimal treatment of early breast cancer.
In this podcast, St. Gallen Consensus Session Co-Chair Giuseppe Curigliano, MD, PhD, European Institute of Oncology & University of Milan, Milan, Italy, is joined by consensus panelists Lisa Carey, MD, FASCO, The University of North Carolina at Chapel Hill, NC, Hope Rugo, MD, FASCO, University of California, San Francisco, CA, and Fatima Cardoso, MD, Champalimaud Clinical Center, Lisbon, Portugal.
Tune in to hear the e...2021-04-2649 minDAWbench Radio ShowEpisode 11 : DAW Evolution IV : Studio One - Past , Present , Future !DAW Evolution IV : Studio One - Past , Present , Future ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Pete Brown of Microsoft and special guest Matthias Juwan, who is the CTO and Co-Founder of PreSonus Software. We discuss Matthias's early years exploring music, computer technology and coding, and how that lead to a career which laid the foundation and framework for the evolution of what became Studio One. We discuss the history and ongoing development of the different incarnations of the core code, and cover Matthias's motivation for the the drag...2021-04-131h 22DAWbench Radio ShowEpisode 10 : DAW Evolution III : Bitwig Studio - Past , Present , Future !DAW Evolution III : Bitwig Studio - Past , Present , Future ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Pete Brown of Microsoft and special guest Claes Johanson , who is the Co-Founder and Lead Developer at Bitwig Studio. We discuss Claes's early musical and technical explorations that lead him to co-found Bitwig , navigate the history and ongoing development of the the different iterations and incarnations of the DAW, discuss Bitwigs unique modular features and approach to driving in the moment creativity and composition. We again dive into the ongoing challenges...2021-03-241h 38DAWbench Radio ShowEpisode 09: DAW Evolution II : Cakewalk - Past , Present , Future !DAW Evolution II : Cakewalk - Past , Present , Future ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Pete Brown of Microsoft and special guest Noel Borthwick, from BandLab Technologies, who leads the Cakewalk development team. We cover Noels musical and technical journey that lead him to Cakewalk , navigate the history and ongoing development of the the different iterations and incarnations of the DAW over a 30 year history, and discuss Cakewalks pioneering work in areas such as Windows 64Bit support, WASAPI, as well as its expanding role within the greater BandLab ecosystem2021-03-052h 05DAWbench Radio ShowEpisode 08: TechBytes 02 : 2020 in Music Tech : Hits and Misses !TechBytes 02 : 2020 in Music Tech : Hits and Misses ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-host Pete Brown who is a Principal Program Manager for Windows & Devices / PAX at Microsoft. We cover the DAWbench 2020's non public show and the large changes made to the 2021 Suite , crown a new King in the audio interface LLP ratings, and give a summary of the new DAW releases from some of the major players. We also discuss the emerging CPU architecture wars involving x86 vs ARM, with Apple, Intel and AMD all...2021-01-171h 56DAWbench Radio ShowEpisode 07: Chip Music : Pushing The Limits of The Past Into The Present !Chip Music : Pushing The Limits of The Past Into The Present ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Erin McKimm, and special guest cTrix. We cover cTrix's explorations of early computers, consoles and electronic music from a very young age , take a deep dive under the bonnet and discuss the finer detail of the synths/chips driving the sound engines of the respective early computers and consoles, and explore the World of Trackers vs Sequencers, etc. We venture into the areas of orchestration for Film/TV using mo...2020-12-051h 49
OncologiaIl Molecular Tumor Board, uno strumento chiave al servizio dell’oncologia di precisioneL'istituzione dei Molecular Tumor Board sta diventando uno strumento sempre più importante in oncologia per realizzare una medicina di precisione e poter offrire al paziente una terapia personalizzata sulla base delle specifiche caratteristiche genetiche del suo tumore. In questa audiointervista, facciamo il punto su questo tema di grandissima attualità nella comunità oncologica con il Professor Giuseppe Curigliano, Direttore della Divisione Sviluppo Nuovi Farmaci per Terapie Innovative e Condirettore del Programma Nuovi Farmaci del Dipartimento di Oncologia ed Emato-Oncologia dell’Università di Milano e dell'Istituto Europeo di Oncologia (IEO) di Milano.2020-11-2413 minOnconewsCOVID-19: recomendações para triagem e tratamento de pacientes com câncer de mamaFátima Cardoso, diretora da Unidade de Mama do Centro Clínico da Fundação Champalimaud e presidente da Advanced Breast Cancer Global Alliance, discute as principais recomendações adotadas pela sociedade europeia de oncologia médica (ESMO) para a triagem e tratamento do câncer de mama durante a pandemia de COVID-19 e o impacto da segunda onda na Europa, com participação dos médicos Felipe Ades e Sílvio Bromberg. Ouça o podcast e assista ao vídeo na TV Onconews.
Referência
Curigliano G, Cardoso MJ, Poortmans P, et al: Recommendations...2020-11-1733 min
OncologiaTumore al seno HER2+ metastatico, aggiunta di tucatinib migliora gli outcomeDal congresso europeo di oncologia medica, l’ESMO, arrivano novità interessanti per i pazienti con tumore della mammella. Infatti, sono stati presentati nuovi dati di uno studio importante, lo studio HER2CLIMB, che dimostrano come l’aggiunta di un nuovo inibitore tirosin chinasico, tucatinib, a trastuzumab più un chemioterapico migliori gli outcome in un gruppo di pazienti con tumore della mammella. Ne parliamo in quest’intervista con uno degli autori dello studio, Giuseppe Curigliano, Professore Associato di Oncologia Medica presso l'Università degli Studi di Milano e Medico Direttore della Divisione Sviluppo Nuovi Farmaci per Terapie Innovative dell'Istituto Europeo di Oncologia di Milano2020-10-2605 minOncologiaCarcinomi midollari della tiroide, pralsetinib terapia promettente nei tumori RET positiviAl congresso europeo di oncologia sono stati presentati i dati dello studio ARROW, in cui il contributo dell’Istituto Europeo di oncologia è stato rilevante. Si tratta di uno studio globale in cui si è testata l’attività di pralsetinib, un farmaco a bersaglio molecolare altamente potente e selettivo, che mira alle alterazioni oncogene del gene RET. Lo studio riporta i dati sui carcinomi midollari della tiroide.Ne parliamo con il prof Giuseppe Curigliano, Direttore della Divisione di Sviluppo di Nuovi Farmaci e Terapie Innovative allo IEO di Milano.2020-10-2302 min
OncologiaTerapia oncologiche a bersaglio molecolare, le ricerche di Menarini presentate a ESMO2020La medicina di precisione si sta sviluppando anche in Italia. Ne parliamo con il prof Giuseppe Curigliano, Direttore della Divisione di Sviluppo di Nuovi Farmaci e Terapie Innovative allo IEO di Milano.2020-10-2301 minOncologiaTumore al seno HR+/HER2-, con abemaciclib nuove prospettive di cura per le pazienti ad alto rischioNovità importanti dal congresso europeo di Oncologia per le donne con tumore al seno HR+/HER2- e ad alto rischio di recidiva. L’aggiunta alla terapia ormonale di un farmaco della classe degli inibitori delle cicline, riduce in misura significativa e clinicamente rilevante il rischio di recidive. Ne parliamo con il prof Giuseppe Curigliano, Direttore della Divisione di Sviluppo di Nuovi Farmaci e Terapie Innovative allo IEO di Milano.2020-10-2304 min
OncologiaTumore al seno HER2+ metastatico, aggiunta di tucatinib migliora gli outcomeDal congresso europeo di oncologia medica, l’ESMO, arrivano novità interessanti per i pazienti con tumore della mammella. Infatti, sono stati presentati nuovi dati di uno studio importante, lo studio HER2CLIMB, che dimostrano come l’aggiunta di un nuovo inibitore tirosin chinasico, tucatinib, a trastuzumab più un chemioterapico migliori gli outcome in un gruppo di pazienti con tumore della mammella. Ne parliamo in quest’intervista con uno degli autori dello studio, Giuseppe Curigliano, Professore Associato di Oncologia Medica presso l'Università degli Studi di Milano e Medico Direttore della Divisione Sviluppo Nuovi Farmaci per Terapie Innovative dell'Istituto Europeo di Oncologia di Milano2020-10-0205 minDAWbench Radio ShowEpisode 06: Windows and DAW’s : 25 Years in the Making !Windows and DAW’s : 25 Years in the Making ! Hosted by Vin Curigliano of AAVIM Technology , I am joined by special guest Pete Brown who is a Principal Program Manager for Windows & Devices / PAX at Microsoft. We cover our first forum encounters, Pete's personal history navigating Music Tech and early forays into computers, his path to Microsoft and eventual position of being a direct liaison to the Music and Audio Tech community. We also discuss his personal studio/synth cave and his mega hardware MIDI rig , sharing some collective musing about some favourite synths of...2020-09-292h 12DAWbench Radio ShowEpisode 05: The Art of Orchestral Sampling : Audio Bro – LASS and Beyond !The Art of Orchestral Sampling : Audio Bro – LASS and Beyond ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Erin McKimm, and special guest Andrew Keresztes, the founder and lead developer at Audio Bro We cover Andrews early foray into DAW benchmarking, which was the catalyst for me heading down the rabbit warren with DAWbench, cover his personal history and career as a professional film/TV composer and what motivated him to become a sample library developer. We also dive under the bonnet of Kontakt to explore why it remains on...2020-07-121h 40
All Things Cardio-OncologyCardio-Oncology in the COVID19 Era: Insights from ItalyDr. Giuseppe Curigliano, Assoc. Professor of Medical Oncology, University of Milan, Italy, discusses Cardio-Oncology practice during the COVID pandemic with the President of ICOS, Dr. Daniel Lenihan, Washington University of St. Louis.2020-05-1924 minDAWbench Radio ShowEpisode 04: TechBytes 01 : DAWbench 2020 Suite, Decade in Music Tech !TechBytes 01 : DAWbench 2020 Suite, Decade in Music Tech ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Leon Herbers of XI Machines. We cover the DAWbench 2020 Suite and Cubendo's exit from the default testing environment after 15 years, a summary of the last decade in Music Tech, the end of Windows 7 official support and what that means for those remaining on the platform. We also discuss the new Mac Pro, the current and emerging high core CPU landscape and how that is panning out regards DAW environments, touch on Linux, navigate...2020-03-211h 27DAWbench Radio ShowEpisode 03: Audio Interface Low Latency Performance : RME – Setting the Bar !Audio Interface Low Latency Performance : RME – Setting the Bar ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Leon Herbers of XI Machines, and special guest Matthias Carstens, the co founder and head of development of RME. We cover history, the driving culture and business philosophy that has elevated RME to be one of the leading and most respected companies in regards audio interface technologies and driver performance. We also dive into some detail of cross platform performance, curves navigated with OSX and Windows 10 , investigate the differing connectivity protocols, US...2019-12-061h 28DAWbench Radio ShowEpisode 02: DAW Evolution : Reaper - Past , Present , Future !DAW Evolution : Reaper - Past , Present , Future ! Hosted by Vin Curigliano of AAVIM Technology, I am joined by guest co-host Erin McKimm, and special guest Justin Frankel, the founder and lead developer of Reaper. We cover the history and ongoing development of Reaper and company culture, Justins involvement with DAWbench over the years, dive into some first hand power user application of the DAW software, revisit and expand on the challenges of navigating DAW multithreading/multiprocessor performance from both an end user and developer perspective We also continue to explore the recent ongoing...2019-11-031h 50DAWbench Radio ShowEpisode 01: DAWbench History : DAW Builder Round TableDAWbench History : DAW Builder Round Table : Hosted by Vin Curigliano of AAVIM Technology , I am joined by guest co-hosts Leon Herbers of XI-MACHINES and Pete Kain of Scan Pro Audio. We cover the History of DAWbench and how it has evolved to being the pseudo industry standard for measuring DAW Performance , past and present curves of navigating the constantly evolving area of multiprocessor support and optimizations , dip our toes into the pro's and con's of hybrid playback engines, and more. Credits and Links. Host & Guest Links : AAVIM Technology : www...2019-08-071h 10
Reeling in the Years - ConnectFM 100.9 Artists chat - Sydney NSW Australia- PodcastJacobs Run - Superman - InterviewJacobs Run is an indie Rock Band Based in Melbourne Victoria , Michael Jacob the lead Singer and writer Joined me for a chat, we learnt about the band which also includes - Fabian Bucci on Drums and Peter Curigliano on Bass. Their Music is available on Digital Sites , and on CD when the Album is released later in 2019
---
Send in a voice message: https://podcasters.spotify.com/pod/show/2bacr90stonow/message2019-08-0612 min
The Pro Audio SuitePimp up your DAWThe Pro Audio Suite Podcast is a Bi-Weekly podcast designed for Audio Professionals. With your Hosts George (The Tech) Whittam, Robert Marshall (Audio Engineer/Source Elements Creator/Owner), Andrew Peters (Premier Voice Talent/Co-Owner Realtime Casting), and Darren "Robbo" Robertson (Studio Owner/Sound Designer), we cover the gamut of Audio issues. From voice Over tips and tools to Project and Professional Studio set up and fit out, to the latest in gear and everything in between. This week is all about the powerhouse behind what we do. It plays back and edits our audio, compresses and EQs, driv...2018-08-1053 min